Pune: In what seems to be a groundbreaking advancement for cardiac care in Maharashtra, Hardas Heart Care has successfully treated a 64-year-old patient suffering from severe Mitral Regurgitation (MR) using India’s first indigenously developed Transcatheter Edge-to-Edge Repair (TEER) system: MyClip, developed by Indian medtech company Meril Life Sciences.
Mr. Bapu Ingale, who had been struggling for two years with severe breathlessness, swollen feet, and inability to perform daily activities, was successfully treated at Hardas Heart Care, Pune, using India’s first Made In India developed Mitral Clip device (MyClip), the first such procedure in Maharashtra performed by Dr. Suhas Hardas.
Diagnosed with Severe Mitral Regurgitation (MR), a condition where blood leaks backward into the heart instead of being pumped to the body, his symptoms had progressively worsened despite medication.
Despite years of medical therapy, his condition continued to worsen, prompting doctors to consider an advanced intervention.
As traditional treatments like open-heart surgery or heart transplant were high-risk and unsuitable given his age, doctors opted for a non-surgical, catheter-based Mitral Valve Repair using the MyClip TEER system, offering a safe and effective alternative.
The procedure was led by Dr. Suhas Hardas, Chief Interventional Cardiologist at Hardas Heart Care, marking the first successful TEER procedure using MyClip in Pune.
Explaining the case, Senior Interventional Cardiologist Dr. Suhas Hardas said: “Patients with severe mitral regurgitation are often at high surgical risk due to age, hypertension, diabetes, obesity, frailty, or co-existing kidney, lung, and liver problems. If untreated, MR has devastating outcomes—more than 50% may not survive, and one-year mortality can be as high as 57%. For such patients, this non-surgical MyClip procedure offers a life-saving alternative.”
The minimally invasive TEER procedure, performed through a small puncture in the thigh, took about an hour.
The patient recovered quickly and was discharged within days. Mr. Bapu Ingale has since resumed his normal daily activities and reported significant improvement in breathing and energy levels.
Around 1.5 million Indians suffer from severe mitral regurgitation, with nearly 1.2 million linked to heart failure or prior heart attacks. In Maharashtra alone, against a population of 13 crore, thousands of elderly patients face similar challenges. Many of them are not improving with medicines and are unfit for surgery or transplant.
For many such patients who are unfit for open-heart surgery or do not respond to medication, the MyClip TEER System offers new hope.
Developed by Meril Life Sciences, the MyClip TEER System enables precise closure of the mitral valve flaps, effectively preventing the backward flow of blood into the lungs. The entire procedure typically takes about an hour, and most patients can return home within 3–5 days.
Until recently, this treatment was available only through expensive imported devices. The introduction of MyClip under the Make in India initiative is a major leap toward accessible cardiac care in India.
The success of this case highlights how the Make in India initiative, along with government support, is enabling world-class, cost-effective treatment options for Indian patients.
